In 2013, Silver, Mayer and Baima defined cancer prehabilitation in the CA: Cancer Journal for Clinicians as “a process on the cancer continuum of care that occurs between the time of cancer diagnosis and the beginning of acute treatment" that is important to establish a baseline and to plan for future impairments. Cancer Prehabilitation is an emerging field in physiatry and oncology. It is an opportunity for program development and expansion of physiatry practice. In this session we will discuss the benefits of early multimodal intervention for cancer patients, including the cost benefits and outcomes. We will present data on prehabilitation research and data on currently active prehabilitation protocols at our own institutions: Prehabilitation for potentially resectable pancreatic cancer: Mouse model data, feasibility data of exercise in patients, and evaluation of tumor vasculature post-prehabilitation. Prehabilitation for breast cancer: breast prehab study for shoulder impairment, discuss mouse model for bone metabolism after fracture. Prehabilitation for pelvic radiation in gynecologic cancer: pelvic exercises to change sacral slope before/during radiation treatment. We will include case presentations of prehabilitation patients: the interventions, outcomes, and clinical pearls. We will also present a pilot multi-disciplinary prehabilitation clinic implemented at a comprehensive cancer center, including the successes and pitfalls.

Learning Objectives

  • Define the goals of a prehabilitation program.
  • Develop an awareness of prehabilitation research.
  • Identify outcome measures for prehabilitation.